Insider trades

Zhenyu Xu, Chief Officer of SOPHiA Genetics SOPH, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $135.9K. The latest trade was on 06/15.

Zhenyu Xu

Chief Scientific Officer
First filing
25/03/24
Trades
17 trades
Buys / sales
0 / 13
12-month net buying
−$135.9K
Last trade
06/15

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/1506/174,000 sh$5.01$20,040−0.6%
Open-market sale10b5-1 plan05/1905/20608 sh$4.60$2,796.8−0.1%
Open-market sale10b5-1 plan05/1305/144,000 sh$4.54$18,160−0.6%
Open-market sale10b5-1 plan04/2004/21608 sh$5.21$3,167.68−0.1%
Open-market sale10b5-1 plan04/1404/16600 sh$4.97$2,982−0.1%
SOPH
Open-market sale10b5-1 plan04/10–04/1304/148,120 sh3 trades$4.72avg.$38,354.72−1.3%
SOPH
Open-market sale10b5-1 plan04/08–04/0904/104,736 sh2 trades$4.80avg.$22,728.64−0.7%
SOPH
Open-market sale10b5-1 plan04/06–04/0704/085,100 sh2 trades$4.86avg.$24,783−0.8%
Open-market sale10b5-1 plan03/1903/20608 sh$4.78$2,906.24−0.1%